Nutraceuticals do not require FDA approval before being marketed, but they must comply with FDA regulations under the Dietary Supplement Health and Education Act (DSHEA), including Good Manufacturing Practice (GMP) standards and accurate labeling requirements.
Answer
Nutraceuticals are products derived from food sources that provide health benefits beyond basic nutrition, including vitamins, minerals, amino acids, herbal extracts, and probiotics. As dietary supplements, nutraceuticals are regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994 rather than the pre-market approval pathway required for pharmaceutical drugs.
Manufacturers are responsible for ensuring that nutraceuticals are safe, correctly labeled, and produced according to FDA-compliant Good Manufacturing Practices (GMPs). These regulations encompass quality control (QC) and quality assurance (QA) protocols, raw material testing, in-process monitoring, and finished product validation. GMP compliance is essential for maintaining product identity, purity, potency, and stability in large-scale manufacturing environments.
In the pharmaceutical and healthcare manufacturing sectors, nutraceuticals are frequently produced by Contract Development and Manufacturing Organizations (CDMOs) and nutraceutical-specific facilities that operate under validated systems. These facilities implement rigorous supply chain management, contaminant testing, and documentation procedures to align with FDA oversight and international quality standards, including EMA and ISO certifications.
While nutraceuticals do not undergo FDA pre-market approval, regulatory compliance remains critical for industry credibility, consumer safety, and market access. Proper adherence to DSHEA, GMP, and QA/QC protocols ensures that nutraceutical products meet legal requirements and maintain consistent quality in competitive healthcare and nutraceutical supply chains.


